Stage
Other Investors | AliveMissing: Pro-Duct Health's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Pro-Duct Health's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Pro-Duct Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pro-Duct Health is included in 1 Expert Collection, including Cancer.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Pro-Duct Health Frequently Asked Questions (FAQ)
Where is Pro-Duct Health's headquarters?
Pro-Duct Health's headquarters is located at Menlo Park.
What is Pro-Duct Health's latest funding round?
Pro-Duct Health's latest funding round is Other Investors.
Who are the investors of Pro-Duct Health?
Investors of Pro-Duct Health include Montreux Equity Partners.
Who are Pro-Duct Health's competitors?
Competitors of Pro-Duct Health include Cyberheart, Avantis Medical Systems, Myomo, DIRAmed, SenoRx and 12 more.
Compare Pro-Duct Health to Competitors
News of a breast biopsy raises many emotions and concerns. The company understand. But it's important to remember that 80% of breast biopsies do not turn out to be breast cancer. It's also important to know that users have options when selecting a biopsy procedure. This site is dedicated to evaluating their choices to help users talk with their doctor about the breast biopsy procedure that is right for users. One of those choices is a minimally invasive breast biopsy for breast cancer diagnosis using the Mammotome Breast Biopsy System. Mammotome is made available by Ethicon Endo-Surgery, Inc.
PreMD Inc. is dedicated to saving and improving people's lives with simple, painless and patient-friendly tests that can detect life-threatening illnesses at a. The company's tests do not require any patient preparation or dietary restrictions and can be performed at the point of care, in a laboratory setting and, in some cases, even at home. The company's cardiovascular risk assessment technology, PREVU* Skin Sterol Test, assesses a patient's risk of heart disease by non-invasively measuring the amount of cholesterol in the skin tissues. PreMD's non- or minimally-invasive tests for early-stage colorectal, lung and breast cancers detect a cancer-associated sugar in a sample of rectal mucus, sputum and breast nipple aspirate fluid, respectively. The company's cancer tests are in development.
Tears For Life, a medical diagnostic equipment company currently developing a non-invasive tear test kit that will be able to screen women for breast cancer using proteins found in their tears.
RadioTherapeutics Corporation is developing tools for minimally invasive treatment of solid tumors. The RF 2000B is used by surgeons, interventional radiologists, and gastroenterologists to predictably, precisely and homogeneously ablate diseased or unwanted volumes of soft tissues.
Arbel-medical develops minimally invasive Cryo-therapy products, for the treatment of breast tumors and other internal diseased tissue.
OrSense provides non-invasive monitoring of various blood constituencies.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.